Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine
Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine

OSAKA, Japan and TOKYO, Japan, Apr 18, 2022 – (JCN Newswire via SEAPRWire.com) – Shionogi & Co., Ltd. and NEC Corporation, today announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. NEC OncoImmunity, an NEC subsidiary that specializes in artificial intelligence-driven biotechnology, is also participating... » read more

IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA

HONG KONG, Feb 17, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that, on 11... » read more

Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries

Cambridge, MA, Feb 16, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company... » read more

NParks monitors wildlife in Singapore to detect, control diseases

SINGAPORE – Since 2011, the National Parks Board (NParks) has been monitoring the local bat population as part of its biosurveillance programme. The programme aims to detect diseases in animals in Singapore, as well as those from other parts of the world. Please subscribe or log in to continue reading the full article. Get unlimited... » read more

DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders
DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders

TOKYO, Mar 17, 2021 – (JCN Newswire via SEAPRWire.com) – Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is... » read more

Broncus Holding Corporation Closed Series D Financing
Broncus Holding Corporation Closed Series D Financing

HONG KONG, Jan 28, 2021 – (ACN Newswire) – Broncus Holding Corporation (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, announced today the closing of a Series D round of funding led by FountainVest Partners. Other investors include Exome Asset Management, Summer Capital, and Valliance Capital. Broncus is dedicated to the... » read more

Broncus Closes Series C Financing
Broncus Closes Series C Financing

HONG KONG, Oct 14, 2020 – (ACN Newswire) – Broncus Holding Company (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, today announced the closing of a Series C round of funding led by Lake Bleu Capital, and including Baidu Capital, the venture arm of one of the world’s largest Internet and... » read more